Thermogenesis Holdings Inc. (THMO)
OTC PINK OTC PINK Primary Summary
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
ThermoGenesis (NASDAQ: THMO ) stock is taking a beating on Wednesday after the company announced an update on its listing compliance. According to a ThermoGenesis filing, it has received another delisting notice from the Nasdaq Exchange.
Thermogenesis Holdings Inc. (THMO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Thermogenesis Holdings Inc. ever had a stock split?
Thermogenesis Holdings Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Xiaochun Xu CEO | OTC PINK Exchange | 88362L209 CUSIP |
| US Country | 25 Employees | - Last Dividend | 5 Jun 2019 Last Split | 18 Aug 1995 IPO Date |
Overview
ThermoGenesis Holdings, Inc., originally known as Cesca Therapeutics Inc. until its name change in November 2019, is a pioneering company focusing on the development, commercialization, and marketing of automated technologies for cell-based therapies, including chimeric antigen receptor (CAR-T) therapies. With a history dating back to 1986 and a base in Rancho Cordova, California, the company is at the forefront of offering automated solutions for clinical biobanking, point-of-care applications, and immuno-oncology. Its innovations are particularly significant in the emerging CAR-T immunotherapy market, providing crucial advancements in the manufacturing process through its semi-automated, functionally closed CAR-TXpress platform. ThermoGenesis Holdings, Inc. is dedicated to addressing the critical needs for large scale cellular processing and chemistry, manufacturing, and controls, thereby contributing significantly to the field of cell-based therapeutic development.
Products and Services
- AXP Automated Cell Separation System - An automated cell separation system designed for isolating stem and progenitor cells from umbilical cord blood.
- BioArchive Automated Cryopreservation System - A robotic, automated system for the controlled-rate-freezing and cryogenic storage of cord blood samples and cell therapeutic products, used in clinical applications.
- PXP Point-of-Care System - An automated, sterile system intended for the processing of autologous peripheral blood or bone marrow aspirate derived stem cells at point-of-care locations such as clinics or surgical centers.
- PXP-LAVARE System - An automated system specialized in washing, re-suspending, and volume reducing cell suspensions.
- PXP-1000 System - An automated system designed for the fast and reproducible separation of multiple cellular components from blood, minimizing red blood cell contamination.
- X-Series Products:
- X-Lab - Focused on cell isolation.
- X-Wash System - Designed for cell washing and reformulation.
- X-Mini - Suited for small scale cell purification.
- X-BACS System (under development) - Targeted for large scale cell purification.
- CAR-TXpress Platform - This platform significantly streamlines the manufacturing process in the CAR-T immunotherapy market by addressing the unmet need for large-scale cellular processing as well as chemistry, manufacturing, and controls (CMC) requirements.
